Princeton, NJ, December 2, 2020 - ClinScape LLC, a clinical innovation consultancy centered around clinical innovation and digital transformation, and Avira Digital, a digital technology and strategy firm, focused on digital engineering, data-modernization, analytics, cloud computing, and IT transparency, both headquartered in Princeton, NJ, have announced a strategic alliance that will bring leadership in digital transformation and clinical innovation to the pharmaceutical and life sciences industries.

   

ClinScape helps Life Sciences companies develop strategies and implement technologies that achieve operational excellence. This includes new paradigms focused on patient engagement, decentralized trials, the use of Real-World Evidence (RWE) along with opportunities to leverage mobile health, advanced analytics, artificial intelligence, and automation. ClinScape’s team brings deep industry knowledge and thought leadership in the areas of clinical development, drug safety, and regulatory compliance.

 

Avira Digital helps life sciences enterprises redefine, reimagine, and reengineer their digital strategy and make technologies accessible with skills, experience and accelerators. With Avira’s innovation lab service, it helps client’s to prove a concept that can be turned into a production pilot very quickly.

 

Through this partnership, the clinical and medical communities will be able to take advantage of deep life sciences subject matter expertise and thought leadership from ClinScape, along with state-of-the art technology platforms and services that leverage big data, cloud computing, mobile technologies, and quality engineering.

 

"The life sciences industry is experiencing radical changes to modernize and accelerate traditional approaches to bring a new drug to market", stated Ken Light, Founding Partner at ClinScape. "New business paradigms are enabled by technology capabilities that didn't exist when good clinical practices were first conceived. Our alliance with Avira will accelerate ClinScape's ability to bring leading digital innovation strategies such as cloud computing, advanced analytics, and digital health to our pharmaceutical and life sciences customers."

 

“Partnering with ClinScape to deliver transformation for our clients in the Life Sciences enterprise will allow us to provide the best business expertise with patient engagement, decentralized trials and in Real-World Evidence (RWE) strategies on which we’ll design, and build the next generation of transformative enterprise and digital solutions,” said Sanjeev Welling, Avira Digital CEO. “Together, working as one team, we will unlock the full potential of digital transformations and place our clients on the best path for success in the new digital business landscape."

 

As part of the commitment to the partnership, ClinScape’s founder, Ken Light will join the advisory board in Avira Digital for pharmaceutical and clinical trial companies.

 

For more information about Avira Digital, visit www.aviradigital.com

For more information about ClinScape, visit www.clinscape.com

​